Projects

The Ministry of Health, Labour and Welfare has granted orphan drug designation to rilzabrutinib, an investigational oral therapy, for the treatment of IgG4-related disease (IgG4-RD).…
Read More...

Recipharm, the contract development and manufacturing organisation (CDMO), announces its new Blow-fill-seal machinery is now operational following a substantial investment last year at…
Read More...

Cambrex Corporation announced that it is expanding its High Point, NC facility with the addition of a new $3.2 million, 11,000 sq. ft. analytical laboratory. The investment comes in…
Read More...

Hebron Technology won a bid on the design and implementation of an oil-free compressed air pipe project at a pharmaceutical production facility owned by Tianjin Chase Sun…
Read More...

Takeda Pharmaceutical has entered into a multi-year partnership with Harrington Discovery Institute at University Hospitals in Cleveland, Ohio to advance the development of rare disease…
Read More...

Sutro Biopharma Inc named Crestovo CEO and COO Joseph M. Lobacki to its board of directors. Mr. Lobacki previously served as chief commercial officer of Medivation. He also served…
Read More...

Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) manufacture at its facility in Research…
Read More...

Amcor Rigid Plastics expands its relationship with long-time customer Campbell Soup Co. with the opening of an on-site bottle manufacturing operation in Paris, Texas. Amcor’s new…
Read More...

Ge announced that United BioPharma Inc. (UBP) has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility in Hsinchu Industrial Park, Taiwan focusing on…
Read More...

Recipharm, the contract development and manufacturing organisation (CDMO), has delivered its first batch of serialised drug products to Saudi Arabia, following the introduction of new…
Read More...

ReForm Biologics, a pharmaceutical technology company that develops proprietary excipients to improve biologic formulations, announced that the Company’s Board of Directors has…
Read More...

RXi Pharmaceuticals announced that Gerrit Dispersyn, Dr. Med Sc. has been appointed as RXi's Chief Development Officer effective April 24, 2017. RXi's current Chief Development…
Read More...

Grifols will donate a minimum of 140 million international units (IU) of blood clotting factor medicines (Factor VIII) to the World Federation of Hemophilia (WFH) Humanitarian Aid…
Read More...

Transgene (Paris:TNG), a company that designs and develops viral-based immunotherapies announces that the first patient with soft tissue sarcoma (STS) has been treated in the Phase 2…
Read More...

Accenture announced its collaboration with BioCelerate to Advance Biopharmaceutical Innovations through Increased Insights in Research & Development. The R&D data sharing…
Read More...

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products announced that it…
Read More...

Sharp Clinical Services (Sharp), part of UDG Healthcare plc has announced a £9 million  investment to fund a new multiple-phase pharmaceutical manufacturing, packaging and distribution…
Read More...

Espero Pharmaceuticals, Inc., a privately held, commercial-stage cardiovascular pharmaceutical company, and Armetheon, Inc., a privately held, late-clinical stage pharmaceutical company…
Read More...

Intec Pharma Ltd., a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, announces the initiation of a…
Read More...

BeiGene, Ltd. and Guangzhou Development District (GDD) announced that BeiGene (Hong Kong) Co., Ltd. (BeiGene HK), a wholly owned subsidiary of BeiGene, Ltd. and GDD and its affiliate…
Read More...